In spite of Preliminary skepticism, recent advancements in peptide drug discovery have rejuvenated curiosity in peptides as therapeutic brokers, with about 70 peptides at this time marketed and several Some others in clinical development.Clinical trials and preclinical studies are highlighted, displaying the efficacy of peptide vaccines in inducing